Prognostic Impact of Myosteatosis on Survival with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis DOI
Taha Koray Şahin, Deniz Can Güven

Clinical Nutrition ESPEN, Journal Year: 2024, Volume and Issue: 63, P. 829 - 836

Published: Aug. 23, 2024

Language: Английский

Application of computed tomography body composition in patients with locally progressive gastric cancer undergoing radical surgery combined with prophylactic hyperthermic intraperitoneal chemotherapy DOI
Wenzhi Wu, Ruiqing Liu, Dongsheng Wang

et al.

Nutrition, Journal Year: 2025, Volume and Issue: 132, P. 112686 - 112686

Published: Jan. 8, 2025

Language: Английский

Citations

0
Subcutaneous adipose tissue [18F]FDG uptake and CT-derived body composition variables for predicting survival outcomes in patients with locally advanced gastric cancer DOI
Xiaoshan Chen, Xiaolin Chen, Xinming Zhao

et al.

European Journal of Nuclear Medicine and Molecular Imaging, Journal Year: 2025, Volume and Issue: unknown

Published: April 24, 2025

Language: Английский

Citations

0
Predictive Factors of Immunotherapy in Gastric Cancer: A 2024 Update DOI Creative Commons
Vasile Bințințan, Claudia Burz,

Irena Pintea

et al.

Diagnostics, Journal Year: 2024, Volume and Issue: 14(12), P. 1247 - 1247

Published: June 13, 2024

Many studies on gastric cancer treatment have identified predictors of immunotherapy benefits. This article provides an update the major developments in research related to predictive factors for cancer. We used search term “predictive factors, immunotherapy, cancer” find most current publications PubMed database Programmed cell death, genetic, and immunological are main study topics immunotherapy’s Other preventive were also found, including clinical tumor microenvironment imaging extracellular factors. Since there is currently no effective cancer, we strongly propose that these be prioritized.

Language: Английский

Citations

1
Evaluating the efficacy of immunotherapy in gastric cancer: Insights from immune checkpoint inhibitors DOI

Yu-Nuo Yang,

Li‐Sheng Wang, Yanqi Dang

et al.

World Journal of Gastroenterology, Journal Year: 2024, Volume and Issue: 30(32), P. 3726 - 3729

Published: Aug. 26, 2024

The emergence of immunotherapy, particularly immune checkpoint inhibitors (ICIs), represents a groundbreaking approach to treating gastric cancer (GC). However, the prognosis GC patients receiving ICI treatment is influenced by various factors. This manuscript identified sarcopenia and myosteatosis as inde-pendent prognostic factors impacting outcomes treated with ICIs. Additionally, this study introduced visual predictive model estimate patients. If confirmed further studies, observation could provide valuable insights propel advancement personalized clinical medicine integration precision practices.

Language: Английский

Citations

1
Prognostic Impact of Myosteatosis on Survival with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis DOI
Taha Koray Şahin, Deniz Can Güven

Clinical Nutrition ESPEN, Journal Year: 2024, Volume and Issue: 63, P. 829 - 836

Published: Aug. 23, 2024

Language: Английский

Citations

0